Related references
Note: Only part of the references are listed.Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma
Y. Nishimura et al.
BRITISH JOURNAL OF CANCER (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
YAP1 oncogene and its eight isoforms
M. Sudol
ONCOGENE (2013)
Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells
Lijuan Wang et al.
PLOS ONE (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation
A. Fernandez-L et al.
ONCOGENE (2012)
FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features
Sara A. Byron et al.
PLOS ONE (2012)
YAP is a candidate oncogene for esophageal squamous cell carcinoma
Tomoki Muramatsu et al.
CARCINOGENESIS (2011)
Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis
Wei Kang et al.
CLINICAL CANCER RESEARCH (2011)
A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial Carcinomas
Meghan L. Rudd et al.
CLINICAL CANCER RESEARCH (2011)
A kinase shRNA screen links LATS2 and the pRB tumor suppressor
Katrin Tschoep et al.
GENES & DEVELOPMENT (2011)
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
X. Zhang et al.
ONCOGENE (2011)
Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
Chad A. Hall et al.
CANCER RESEARCH (2010)
Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer
Yang Wang et al.
CANCER SCIENCE (2010)
Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology Revisited
Frank Pajonk et al.
STEM CELLS (2010)
Yes-Associated Protein Is an Independent Prognostic Marker in Hepatocellular Carcinoma
Michelle Z. Xu et al.
CANCER (2009)
YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation
Africa Fernandez-L et al.
GENES & DEVELOPMENT (2009)
Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship
Amanda Nickles Fader et al.
GYNECOLOGIC ONCOLOGY (2009)
The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas
David G. Mutch
GYNECOLOGIC ONCOLOGY (2009)
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
Dawn R. Cochrane et al.
MOLECULAR CANCER THERAPEUTICS (2009)
YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway
Jianmin Zhang et al.
NATURE CELL BIOLOGY (2009)
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
H. B. Salvesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation
Toshihiko Yokoyama et al.
CARCINOGENESIS (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Expression of Yes-associated protein in common solid tumors
Angela A. Steinhardt et al.
HUMAN PATHOLOGY (2008)
Mst2 and lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP)
Tsutomu Oka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
ZEB1 expression in type I vs type II endometrial cancers:: a marker of aggressive disease
Meenakshi Singh et al.
MODERN PATHOLOGY (2008)
Drug-sensitive FGFR2 mutations in endometrial carcinoma
Amit Dutt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
Models representing type I and type II human endometrial cancers: Ishikawa H and Hec50co cells
Lina Albitar et al.
GYNECOLOGIC ONCOLOGY (2007)
Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics
Piergiorgio Modena et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization
Yael Aylon et al.
GENES & DEVELOPMENT (2006)
WW domain binding protein-2, an E6-associated protein interacting protein, acts as a coactivator of estrogen and progesterone receptors
Sarath C. Dhananjayan et al.
MOLECULAR ENDOCRINOLOGY (2006)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Lars Zender et al.
CELL (2006)
Non-endometrioid carcinomas of the uterine corpus: A review of their pathology with emphasis on recent advances and problematic aspects
PB Clement et al.
ADVANCES IN ANATOMIC PATHOLOGY (2004)
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
HM Keys et al.
GYNECOLOGIC ONCOLOGY (2004)
Role of cell cycle in mediating sensitivity to radiotherapy
TM Pawlik et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Survival after relapse in patients with endometrial cancer:: results from a randomized trial
CL Creutzberg et al.
GYNECOLOGIC ONCOLOGY (2003)
Endometrioid carcinoma of the uterine corpus: A review of its pathology with emphasis on recent advances and problematic aspects
PB Clement et al.
ADVANCES IN ANATOMIC PATHOLOGY (2002)
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma:: multicentre randomised trial
CL Creutzberg et al.
LANCET (2000)
Share Paper
